Alvaro Padilla, MD
Neurology · Hollywood, FLNPI 1235180001
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $80,690 of the $91,264 with a category attached, or 88.4%. AbbVie accounts for 61.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $35,192 and has fallen 99.6% since, to $151 in 2024. Among neurology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $651.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$56K
- Lilly USA, LLC$35K
- Inspire Medical Systems, Inc.$200
- Penumbra, Inc.$116
- Johnson & Johnson$34
Across 4 payments — averaging $3406.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
What the payments were for
- Consulting fees$3,3254%
- Speaking & faculty fees$80,69088%
- Travel & lodging$4,6345%
- Food & beverage$2,6083%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $55,723 |
| Lilly USA, LLC | 88 | $35,192 |
| Inspire Medical Systems, Inc. | 1 | $200 |
| Penumbra, Inc. | 1 | $116 |
| Johnson & Johnson | 2 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$55,330
- Inspire$200
- Penumbra System$116
How this compares
$91,264 in reported general payments places this provider in the 90th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Hollywood
- Buse SengulHollywood$189K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.